Lumida
/VERA
⌘K
Vera Therapeutics Inc

Vera Therapeutics Inc

VERA
$38.50USD-1.58%-0.62 today

MARKET CAP

2.8B

P/E (TTM)

FWD P/E

DAY RANGE

$38 – $40

52W RANGE

$19
$56

AI Summary

Stalk
Buy NowHigh

VERA remains in a Stage 2 advancing regime with dynamic support from rising EMAs and an active Lockout Rally indicating forced short covering and sustained upside momentum. Price is consolidating above the 9-/20-EMA zone without signs of exhaustion, making now a favorable entry to participate in the continuation of the uptrend. We recommend buying on shallow pullbacks into these trend-support EMAs.

  • July 7, 2026 FDA accelerated approval shifts Vera to commercial stage, spurring stock rally
  • High institutional ownership signals robust investor backing post-approval
  • Crowded IgAN market with competitors like VRTX and Novartis may pressure Trutakna pricing
Full analysis →
Insider Trades37 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 7, 2026SellVERAMarshall FordycePRESIDENT AND CEO46,250$42.30$2.8B-31.31%+101.93%$2.0M-6.47%10b5-1Buy Now
Jun 23, 2026SellVERAMarshall FordycePRESIDENT AND CEO18,500$37.93$2.8B-31.31%+101.93%$701.8K-4.46%10b5-1Buy Now
May 12, 2026SellVERAMarshall FordycePRESIDENT AND CEO18,500$36.74$2.8B-31.31%+101.93%$679.7K-4.05%10b5-1Buy Now
Apr 14, 2026SellVERAMarshall FordycePRESIDENT AND CEO22,951$44.05$2.8B-31.31%+101.93%$1.0M-3.11%10b5-1Buy Now
Mar 13, 2026BuyVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR10,000$3.94$2.8B-31.31%+101.93%$39.4K+9.58%Buy Now
Feb 23, 2026SellVERALaurence Matthew SkeltonChief Commercial Officer1,582$41.98$2.8B-31.31%+101.93%$66.4K-2.40%Buy Now
Feb 23, 2026SellVERARobert BrennerChief Medical Officer2,151$41.98$2.8B-31.31%+101.93%$90.3K-4.05%Buy Now
Feb 23, 2026SellVERAWilliam D. TurnerChief Regulatory Officer2,187$41.98$2.8B-31.31%+101.93%$91.8K-4.60%Buy Now
Feb 23, 2026SellVERADavid Lee JohnsonChief Operating Officer2,579$41.98$2.8B-31.31%+101.93%$108.3K-5.34%Buy Now
Feb 23, 2026SellVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR3,117$41.98$2.8B-31.31%+101.93%$130.9K-4.59%Buy Now
Feb 23, 2026SellVERASean GrantCHIEF FINANCIAL OFFICER4,949$41.98$2.8B-31.31%+101.93%$207.8K-4.15%Buy Now
Feb 23, 2026SellVERAMarshall FordycePRESIDENT AND CEO16,925$41.98$2.8B-31.31%+101.93%$710.6K-6.18%Buy Now
Dec 15, 2025SellVERAWilliam D. TurnerChief Regulatory Officer20,000$32.80$2.8B-31.31%+101.93%$656.1K+0.00%10b5-1Buy Now
Dec 8, 2025SellVERAWilliam D. TurnerChief Regulatory Officer20,000$30.42$2.8B-31.31%+101.93%$608.4K+0.00%10b5-1Buy Now
Dec 3, 2025SellVERAWilliam D. TurnerChief Regulatory Officer20,000$27.77$2.8B-31.31%+101.93%$555.3K+0.00%10b5-1Buy Now
Nov 21, 2025SellVERAJason S CarterChief Legal Officer3,864$27.82$2.8B-31.31%+101.93%$107.5K-7.29%Buy Now
Nov 11, 2025SellVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR25,000$19.01$2.8B-31.31%+101.93%$475.3K-3.14%Buy Now
Feb 21, 2025SellVERAMarshall FordycePRESIDENT AND CEO19,688$27.78$2.8B-31.31%+101.93%$546.9K-3.06%10b5-1Buy Now
Jan 8, 2025SellVERAMarshall FordycePRESIDENT AND CEO35,000$22.32$2.8B-31.31%+101.93%$781.2K+0.00%10b5-1Buy Now
Dec 18, 2024BuyVERAMarshall FordycePRESIDENT AND CEO92,661$10.48$2.8B-31.31%+101.93%$971.4K+1.95%10b5-1Buy Now
Dec 11, 2024SellVERAMarshall FordycePRESIDENT AND CEO35,000$24.92$2.8B-31.31%+101.93%$872.2K+0.00%10b5-1Buy Now
Nov 25, 2024SellVERAMarshall FordycePRESIDENT AND CEO38,750$25.44$2.8B-31.31%+101.93%$985.7K+0.00%10b5-1Buy Now
Nov 13, 2024SellVERAMarshall FordycePRESIDENT AND CEO61,250$26.20$2.8B-31.31%+101.93%$1.6M+0.00%10b5-1Buy Now
Oct 23, 2024SellVERAMarshall FordycePRESIDENT AND CEO38,750$21.64$2.8B-31.31%+101.93%$838.7K+0.00%10b5-1Buy Now
Oct 9, 2024SellVERAMarshall FordycePRESIDENT AND CEO31,250$20.57$2.8B-31.31%+101.93%$642.8K+0.00%10b5-1Buy Now
Sep 25, 2024SellVERAMarshall FordycePRESIDENT AND CEO46,250$24.47$2.8B-31.31%+101.93%$1.1M+0.00%10b5-1Buy Now
Sep 11, 2024SellVERAMarshall FordycePRESIDENT AND CEO31,250$20.20$2.8B-31.31%+101.93%$631.2K+0.00%10b5-1Buy Now
Aug 28, 2024SellVERAMarshall FordycePRESIDENT AND CEO45,945$25.30$2.8B-31.31%+101.93%$1.2M-0.53%10b5-1Buy Now
Aug 21, 2024SellVERAMarshall FordycePRESIDENT AND CEO14,471$39.76$2.8B-31.31%+101.93%$575.4K-4.29%10b5-1Buy Now
Aug 14, 2024SellVERAMarshall FordycePRESIDENT AND CEO31,250$20.23$2.8B-31.31%+101.93%$632.2K+0.00%10b5-1Buy Now
May 15, 2024SellVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR59,709$25.11$2.8B-31.31%+101.93%$1.5M-0.38%Buy Now
Apr 10, 2024SellVERAJoseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR5,714$40.00$2.8B-31.31%+101.93%$228.6K-9.70%Buy Now
Apr 3, 2024SellVERASean GrantCHIEF FINANCIAL OFFICER218,305$28.28$2.8B-31.31%+101.93%$6.2M-2.98%Buy Now
Dec 29, 2023BuyVERAMarshall FordycePresident and CEO13,516$2.87$2.8B-31.31%+101.93%$38.9K+0.99%Buy Now
Aug 21, 2023SellVERACelia LinChief Medical Officer1,490$16.65$2.8B-31.31%+101.93%$24.8K-11.92%10b5-1Buy Now
Aug 21, 2023SellVERAJoanne CurleyChief Development Officer1,490$16.66$2.8B-31.31%+101.93%$24.8K-5.24%10b5-1Buy Now
Aug 21, 2023SellVERAMarshall FordycePresident and CEO5,210$16.66$2.8B-31.31%+101.93%$86.8K-2.10%10b5-1Buy Now